Denmark· DK-28107263624

Livmarli

A maralixibat chloride product containing maralixibatchlorid, registered in Denmark by Mirum Pharmaceuticals International B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A05AX04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedLivmarliATCA05AX04REGISTER NO.DK-28107263624PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Maralixibat chloride is registered in 11 of 19 countries.

Countries holding a registration under ATC A05AX04 (maralixibat chloride), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 6 of them publish a price we can compare per daily dose

Maralixibat chloride · ATC A05AX04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Maralixibatchlorid
Manufacturer
Mirum Pharmaceuticals International B.V.
Country
Denmark (DK)
ATC code
A05AX04
ATC class
Maralixibat chloride
Defined daily dose
28.5 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107263624

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9528544-4d86-40fa-b575-fb70e0247991
GET /v1/drugs/e9528544-4d86-40fa-b575-fb70e0247991?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter",
  "source": "dkma",
  "strength": "20 mg",
  "auth_role": "CO-RAP",
  "dk_drugid": "28107263624",
  "substance": "Maralixibatchlorid",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "44904"
}

See everything about maralixibat chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.